Literature DB >> 8491527

Penetration of ofloxacin into prostatic fluid, ejaculate and seminal fluid.

K G Naber1, M Kinzig, F Sörgel, D Weigel.   

Abstract

The penetration of ofloxacin into prostatic fluid, ejaculate and seminal fluid was measured by a high-pressure liquid chromatography (HPLC) method after intravenous infusion (60 min) of 400 mg in six healthy male volunteers. The median concentration of ofloxacin in prostatic fluid was about one-third and that in ejaculate and seminal fluid about twice that in corresponding plasma. The results of the study indicate good penetration of ofloxacin into prostatic fluid, ejaculate and seminal fluid. Ofloxacin should thus be of value for the treatment of chronic bacterial prostatitis and vesiculitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491527     DOI: 10.1007/BF01710740

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  7 in total

Review 1.  The role of quinolones in the treatment of chronic bacterial prostatitis.

Authors:  K G Naber
Journal:  Infection       Date:  1991       Impact factor: 3.553

2.  In-vitro activity of fleroxacin against isolates causing complicated urinary tract infections and concentrations in seminal and prostatic fluid and in prostatic adenoma tissue.

Authors:  K G Naber; F Sörgel; F Kees; H Schumacher; R Metz; H Grobecker
Journal:  J Antimicrob Chemother       Date:  1988-10       Impact factor: 5.790

3.  In vitro activity and concentrations in serum, urine, prostatic secretion and adenoma tissue of ofloxacin in urological patients.

Authors:  K G Naber; D Adam; F Kees
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Concentration of ofloxacin and ciprofloxacin in human semen following a single oral dose.

Authors:  S A Berger; H Yavetz; G Paz; A Gorea; Z Homonnai
Journal:  J Urol       Date:  1990-09       Impact factor: 7.450

5.  Concentrations of cefpodoxime in plasma, ejaculate and in prostatic fluid and adenoma tissue.

Authors:  K G Naber; M Kinzig; D Adam; F Sörgel; A H Bajorski; R Kiehn
Journal:  Infection       Date:  1991 Jan-Feb       Impact factor: 3.553

6.  Ofloxacin: concentration in human ejaculate and influence on sperm motility.

Authors:  P Schramm
Journal:  Infection       Date:  1986       Impact factor: 3.553

7.  [Laboratory and clinical study of ofloxacin in the treatment of bacterial prostatitis].

Authors:  K Suzuki; H Tamai; Y Naide; K Ando; R Moriguchi
Journal:  Hinyokika Kiyo       Date:  1984-10
  7 in total
  6 in total

1.  Fluoroquinolone Antimicrobial Agents in the Treatment of Prostatitis and Recurrent Urinary Tract Infections in Men.

Authors:  F M E Wagenlehner; K G Naber
Journal:  Curr Infect Dis Rep       Date:  2005-01       Impact factor: 3.725

2.  Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administrations of 400 milligrams to volunteers.

Authors:  C K Naber; M Steghafner; M Kinzig-Schippers; C Sauber; F Sörgel; H J Stahlberg; K G Naber
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

Review 3.  Ofloxacin. A reappraisal of its use in the management of genitourinary tract infections.

Authors:  S V Onrust; H M Lamb; J A Balfour
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

Review 4.  Pharmacological Interventions for Bacterial Prostatitis.

Authors:  Situ Xiong; Xiaoqiang Liu; Wen Deng; Zhengtao Zhou; Yulei Li; Yechao Tu; Luyao Chen; Gongxian Wang; Bin Fu
Journal:  Front Pharmacol       Date:  2020-04-30       Impact factor: 5.810

5.  Antibiotic therapy of chronic bacterial prostatitis is more effective considering antibiotic susceptibility of all pathogens isolated.

Authors:  Mikhail I Kogan; Khalid S Ibishev; Yulia L Naboka; Irina A Gudima; Akhmed Kh Ferzauli; Ruslan S Ismailov; Kurt G Naber
Journal:  Investig Clin Urol       Date:  2022-04-05

Review 6.  Fluoroquinolone antimicrobial agents in the treatment of prostatitis and recurrent urinary tract infections in men.

Authors:  F M E Wagenlehner; K G Naber
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 2.862

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.